1. Home
  2. VTRS vs WES Comparison

VTRS vs WES Comparison

Compare VTRS & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • WES
  • Stock Information
  • Founded
  • VTRS 1961
  • WES 2007
  • Country
  • VTRS United States
  • WES United States
  • Employees
  • VTRS N/A
  • WES N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • WES Natural Gas Distribution
  • Sector
  • VTRS Health Care
  • WES Utilities
  • Exchange
  • VTRS Nasdaq
  • WES Nasdaq
  • Market Cap
  • VTRS 13.0B
  • WES 15.4B
  • IPO Year
  • VTRS N/A
  • WES 2008
  • Fundamental
  • Price
  • VTRS $11.25
  • WES $41.22
  • Analyst Decision
  • VTRS Hold
  • WES Hold
  • Analyst Count
  • VTRS 3
  • WES 9
  • Target Price
  • VTRS $13.67
  • WES $38.00
  • AVG Volume (30 Days)
  • VTRS 9.5M
  • WES 1.4M
  • Earning Date
  • VTRS 02-27-2025
  • WES 02-26-2025
  • Dividend Yield
  • VTRS 4.27%
  • WES 8.51%
  • EPS Growth
  • VTRS N/A
  • WES 44.12
  • EPS
  • VTRS N/A
  • WES 3.91
  • Revenue
  • VTRS $15,048,500,000.00
  • WES $3,534,928,000.00
  • Revenue This Year
  • VTRS N/A
  • WES $19.69
  • Revenue Next Year
  • VTRS N/A
  • WES $2.15
  • P/E Ratio
  • VTRS N/A
  • WES $10.52
  • Revenue Growth
  • VTRS N/A
  • WES 16.75
  • 52 Week Low
  • VTRS $9.93
  • WES $33.15
  • 52 Week High
  • VTRS $13.62
  • WES $43.33
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 52.72
  • WES 52.90
  • Support Level
  • VTRS $10.74
  • WES $39.53
  • Resistance Level
  • VTRS $11.02
  • WES $41.78
  • Average True Range (ATR)
  • VTRS 0.21
  • WES 0.87
  • MACD
  • VTRS 0.08
  • WES 0.01
  • Stochastic Oscillator
  • VTRS 91.82
  • WES 75.44

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests

Western Midstream Partners LP is a US-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.

Share on Social Networks: